Viewing nowCarnil Tablets (L-Carnitine)
L-Carnitine 330mg
Tablet · OTC medication
Intro Bio Pharma Co., Ltd.

MFDS item code 201900317 · Notified 2019.01.22
Treatment of carnitine deficiency and myocardial metabolic disorders due to ischemic heart disease
This medication is used to improve metabolic disorders associated with primary and secondary carnitine deficiency. It also helps treat myocardial metabolic disorders due to ischemic heart disease, such as angina and acute myocardial infarction. This medication is used to effectively manage these conditions.
Adults: Administer 2-3 g per day of L-carnitine orally in 2-3 divided doses (take by mouth). Adjust the dose as appropriate according to age and symptoms.
This medication should not be administered to certain patients. For example, patients who show allergic reactions to this medication or have hypersensitivity to soybean oil, soy, peanuts, etc., should not take this medication. In addition, it should be used cautiously in patients with lipid metabolism issues such as hyperlipoproteinemia or diabetic dyslipidemia, and pancreatitis, as these patients may have symptoms worsened by the fat content of this medication. When taking this medication, temporary symptoms of nausea or vomiting, abdominal pain, diarrhea, and changes in body odor may occur. Rarely, skin rash or hives, facial swelling may also be reported; if these symptoms occur, consult a physician immediately. Particularly in patients with poor kidney function, muscle weakness symptoms may manifest, so caution is necessary. Generally, for patients expected to have fat overload, it is advisable to regularly monitor blood lipid levels when using this medication. If lipid levels are high, the dosage of this medication must be adjusted; and if other lipid-containing intravenous preparations are used together, the dose should be reduced considering the fat content. Women who are pregnant or may become pregnant should use this medication only when the benefits of treatment outweigh the risks, as the safety of this medication is not established. Additionally, nursing women should take this medication cautiously, as it may be transmitted through breast milk.
Not everyone experiences these, and they can vary from person to person.
This medication should be discussed with a doctor or pharmacist if used in conjunction with intravenous lipid preparations.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is advisable to maintain the storage temperature between 1 degree and 30 degrees Celsius.
White, round film-coated tablet
90 tablets/PTP (10 tablets/PTP * 9)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowL-Carnitine 330mg
Tablet · OTC medication
Intro Bio Pharma Co., Ltd.
L-Carnitine 200mg
Prescription medication
Albozen Korea Co., Ltd.

L-Carnitine 330mg
Tablet · OTC medication
Seoul Pharmaceutical Co., Ltd.
L-Carnitine 330mg
Tablet · OTC medication
HLB Pharmaceuticals Co., Ltd.

L-Carnitine 330mg
Tablet · OTC medication
Daehan New Pharm Co., Ltd.

L-Carnitine 330mg
Tablet · OTC medication
Gyeongnam Pharmaceutical Co., Ltd.

L-Carnitine 330mg
Tablet · OTC medication
SS Pharm Co., Ltd.

L-Carnitine 330mg
Tablet · OTC medication
Mothers Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.